Last 12 months
Inside the activity.
0 purchase rows · 40 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 20, 2022 Filed Jul 21, 2022 20:43 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 55,581 | $34.03 | $1,891,421.43 |
DisclosureSEC source: 0001759655-22-000105 · wf-form4_165843619443320.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,810 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.41 to $34.40 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 20, 2022 Filed Jul 21, 2022 20:43 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 60,000 | $2.00 | $120,000.00 |
DisclosureSEC source: 0001759655-22-000105 · wf-form4_165843619443320.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 20:43 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 112,983 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000106 · wf-form4_165843621567150.xml · derivative · entry 7 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,120,795 Underlying: Common Stock · 112,983 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 4,343,688 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022. Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 20:43 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 59,586 | $34.26 | $2,041,416.36 |
DisclosureSEC source: 0001759655-22-000106 · wf-form4_165843621567150.xml · nonDerivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,739 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.13 to $34.71 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 20:43 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 53,397 | $33.92 | $1,811,226.24 |
DisclosureSEC source: 0001759655-22-000106 · wf-form4_165843621567150.xml · nonDerivative · entry 2 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,325 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.13 to $34.12 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 19, 2022 Filed Jul 21, 2022 20:43 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 112,983 | $2.00 | $225,966.00 |
DisclosureSEC source: 0001759655-22-000106 · wf-form4_165843621567150.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,722 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 20:53 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 51,756 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000099 · wf-form4_165826399828770.xml · derivative · entry 7 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,812 Underlying: Common Stock · 51,756 shares Expires 2029-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 79,753 of the stock options are fully vested and exercisable. 17,244 of the stock options will vest on October 29, 2022. F5 · derivative.expiration_date: These stock options were previously reported on the Form 3 filed by the Reporting Person with an Expiration Date that was incorrectly stated as 03/31/2029. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 20:53 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, par value $0.01 per share | 25 | $35.00 | $875.00 |
DisclosureSEC source: 0001759655-22-000099 · wf-form4_165826399828770.xml · nonDerivative · entry 5 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,392 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 20:53 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, par value $0.01 per share | 24,990 | $34.06 | $851,159.40 |
DisclosureSEC source: 0001759655-22-000099 · wf-form4_165826399828770.xml · nonDerivative · entry 4 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,417 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.81 to $34.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 18, 2022 Filed Jul 19, 2022 20:53 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock, par value $0.01 per share | 51,756 | $2.00 | $103,512.00 |
DisclosureSEC source: 0001759655-22-000099 · wf-form4_165826399828770.xml · nonDerivative · entry 3 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 27,265 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000100 · wf-form4_165826401947482.xml · derivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,505,692 Underlying: Common Stock · 27,265 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,259,398 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 3,827 | $35.01 | $133,971.79 |
DisclosureSEC source: 0001759655-22-000100 · wf-form4_165826401947482.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.04 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, par value $0.01 per share | 23,438 | $34.74 | $814,306.43 |
DisclosureSEC source: 0001759655-22-000100 · wf-form4_165826401947482.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,218 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.00 to $34.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock, par value $0.01 per share | 27,265 | $2.00 | $54,530.00 |
DisclosureSEC source: 0001759655-22-000100 · wf-form4_165826401947482.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 3,429 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000099 · wf-form4_165826399828770.xml · derivative · entry 6 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,568 Underlying: Common Stock · 3,429 shares Expires 2029-03-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 79,753 of the stock options are fully vested and exercisable. 17,244 of the stock options will vest on October 29, 2022. F5 · derivative.expiration_date: These stock options were previously reported on the Form 3 filed by the Reporting Person with an Expiration Date that was incorrectly stated as 03/31/2029. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, par value $0.01 per share | 3,429 | $35.00 | $120,021.86 |
DisclosureSEC source: 0001759655-22-000099 · wf-form4_165826399828770.xml · nonDerivative · entry 2 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,651 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.015 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 20:53 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock, par value $0.01 per share | 3,429 | $2.00 | $6,858.00 |
DisclosureSEC source: 0001759655-22-000099 · wf-form4_165826399828770.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:26 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 90,553 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000096 · wf-form4_165757118885230.xml · derivative · entry 7 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,233,778 Underlying: Common Stock · 90,553 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 4,503,153 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:26 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 42,743 | $34.24 | $1,463,563.06 |
DisclosureSEC source: 0001759655-22-000096 · wf-form4_165757118885230.xml · nonDerivative · entry 5 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,739 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.00 to $34.79 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:26 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 47,810 | $33.68 | $1,610,001.75 |
DisclosureSEC source: 0001759655-22-000096 · wf-form4_165757118885230.xml · nonDerivative · entry 4 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,482 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.10 to $33.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:26 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 90,553 | $2.00 | $181,106.00 |
DisclosureSEC source: 0001759655-22-000096 · wf-form4_165757118885230.xml · nonDerivative · entry 3 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:26 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 12,735 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000095 · wf-form4_165757117090739.xml · derivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,532,957 Underlying: Common Stock · 12,735 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 1,272,133 of the stock options are fully vested and exercisable. 273,559 of the stock options will vest on October 29, 2022. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:26 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock | 12,735 | $34.23 | $435,880.85 |
DisclosureSEC source: 0001759655-22-000095 · wf-form4_165757117090739.xml · nonDerivative · entry 2 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $34.00 to $34.74 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 08, 2022 Filed Jul 11, 2022 20:26 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionCommon Stock | 12,735 | $2.00 | $25,470.00 |
DisclosureSEC source: 0001759655-22-000095 · wf-form4_165757117090739.xml · nonDerivative · entry 1 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 2,492 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000091 · wf-form4_165731930123474.xml · derivative · entry 3 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,369 Underlying: Common Stock · 2,492 shares Expires 2029-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 8,930 of the stock options are fully vested and exercisable. 6,438 of the stock options will vest on October 29, 2022 and 2,493 of the stock options will vest December 4, 2022. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock | 1,212 | $32.35 | $39,202.14 |
DisclosureSEC source: 0001759655-22-000091 · wf-form4_165731930123474.xml · nonDerivative · entry 2 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,651 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. Read SEC document |
| July 07, 2022 Filed Jul 8, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 2,492 | $2.00 | $4,984.00 |
DisclosureSEC source: 0001759655-22-000091 · wf-form4_165731930123474.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 20:26 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 68,912 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000096 · wf-form4_165757118885230.xml · derivative · entry 6 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,324,331 Underlying: Common Stock · 68,912 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. Prior to the transactions reported in this Form 4, 4,503,153 of the stock options were fully vested and exercisable. 890,090 of the stock options vest on October 29, 2022. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 20:26 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
SaleCommon Stock, $0.01 par value per share | 68,912 | $33.24 | $2,290,634.88 |
DisclosureSEC source: 0001759655-22-000096 · wf-form4_165757118885230.xml · nonDerivative · entry 2 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,739 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021, as amended on November 18, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.5432.65 to $33.59 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 07, 2022 Filed Jul 11, 2022 20:26 UTC |
Morris Matthew ShawnDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 68,912 | $2.00 | $137,824.00 |
DisclosureSEC source: 0001759655-22-000096 · wf-form4_165757118885230.xml · nonDerivative · entry 1 Morris Matthew Shawn · CIK 0001401958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 20,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000089 · wf-form4_165723292024937.xml · derivative · entry 10 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,666 Underlying: Common Stock · 20,000 shares Expires 2030-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 26,666 of the stock options are fully vested and exercisable. 4,167 of the stock options will vest on September 8, 2022, 6,667 of the stock options vest on October 29, 2022 and 4,166 of the stock options will vest on September 8, 2023. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, $0.01 par value per share | 10 | $31.06 | $310.60 |
DisclosureSEC source: 0001759655-22-000089 · wf-form4_165723292024937.xml · nonDerivative · entry 8 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,371 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, $0.01 par value per share | 9,723 | $30.75 | $298,982.25 |
DisclosureSEC source: 0001759655-22-000089 · wf-form4_165723292024937.xml · nonDerivative · entry 7 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. Read SEC document |
| July 06, 2022 Filed Jul 7, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 20,000 | $2.00 | $40,000.00 |
DisclosureSEC source: 0001759655-22-000089 · wf-form4_165723292024937.xml · nonDerivative · entry 6 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:25 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 14,952 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000087 · wf-form4_165723274181667.xml · derivative · entry 5 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,300 Underlying: Common Stock · 14,952 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 300,150 of the stock options are fully vested and exercisable. 64,102 of the stock options will vest on October 29, 2022. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:25 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 442 | $32.37 | $14,307.54 |
DisclosureSEC source: 0001759655-22-000087 · wf-form4_165723274181667.xml · nonDerivative · entry 4 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,355 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.02 to $33.02 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:25 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 1,067 | $31.23 | $33,322.41 |
DisclosureSEC source: 0001759655-22-000087 · wf-form4_165723274181667.xml · nonDerivative · entry 3 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.00 to $31.54 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:25 UTC |
Bartrum ThomasEVP, General Counsel
|
SaleCommon Stock, $0.01 par value per share | 13,443 | $30.63 | $411,759.09 |
DisclosureSEC source: 0001759655-22-000087 · wf-form4_165723274181667.xml · nonDerivative · entry 2 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,864 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.97 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:25 UTC |
Bartrum ThomasEVP, General Counsel
|
Exercise / conversionCommon Stock, $0.01 par value per share | 14,952 | $2.00 | $29,904.00 |
DisclosureSEC source: 0001759655-22-000087 · wf-form4_165723274181667.xml · nonDerivative · entry 1 Bartrum Thomas · CIK 0001859681 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 19,280 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000089 · wf-form4_165723292024937.xml · derivative · entry 9 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,861 Underlying: Common Stock · 19,280 shares Expires 2029-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 28,210 of the stock options are fully vested and exercisable. 6,438 of the stock options will vest on October 29, 2022 and 2,493 of the stock options will vest December 4, 2022. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, $0.01 par value per share | 100 | $33.42 | $3,342.00 |
DisclosureSEC source: 0001759655-22-000089 · wf-form4_165723292024937.xml · nonDerivative · entry 5 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,104 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, $0.01 par value per share | 500 | $32.21 | $16,105.00 |
DisclosureSEC source: 0001759655-22-000089 · wf-form4_165723292024937.xml · nonDerivative · entry 4 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,204 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.08 to $32.40 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, $0.01 par value per share | 1,100 | $31.35 | $34,485.00 |
DisclosureSEC source: 0001759655-22-000089 · wf-form4_165723292024937.xml · nonDerivative · entry 3 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,704 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.03 to $31.97 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
SaleCommon Stock, $0.01 par value per share | 17,580 | $30.63 | $538,475.40 |
DisclosureSEC source: 0001759655-22-000089 · wf-form4_165723292024937.xml · nonDerivative · entry 2 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,804 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.97 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:28 UTC |
Mountcastle DavidEVP & Chief Financial Officer
|
Exercise / conversionCommon Stock, $0.01 par value per share | 19,280 | $2.00 | $38,560.00 |
DisclosureSEC source: 0001759655-22-000089 · wf-form4_165723292024937.xml · nonDerivative · entry 1 Mountcastle David · CIK 0001858396 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC |
Mehrotra ParthPresident and COO
|
Exercise / conversionStock Option (Right to Purchase) · Derivative | 40,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · derivative · entry 7 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,545,692 Underlying: Common Stock · 40,000 shares Expires 2033-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 1,312,132 of the stock options are fully vested and exercisable. 273,560 of the stock options will vest on October 29, 2022. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 300 | $32.50 | $9,750.00 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 6 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,391 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.43 to $32.54 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 1,137 | $31.36 | $35,656.32 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 5 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,691 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.07 to $31.95 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 15,594 | $30.64 | $477,800.16 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 4 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,828 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.02 to $30.98 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 22:26 UTC |
Mehrotra ParthPresident and COO
|
SaleCommon Stock, $0.01 par value per share | 20,979 | $29.41 | $616,992.39 |
DisclosureSEC source: 0001759655-22-000088 · wf-form4_165723279734220.xml · nonDerivative · entry 3 Mehrotra Parth · CIK 0001858398 · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,422 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.02 to $29.99 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.